Global Approved COVID-19 Vaccines Market Research Report 2024

Report ID: 1878125 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Approved COVID-19 Vaccines Market Overview
    1.1 Product Overview and Scope of Approved COVID-19 Vaccines
    1.2 Approved COVID-19 Vaccines Segment by Type
        1.2.1 Global Approved COVID-19 Vaccines Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Component Viral Vaccines
        1.2.3 Whole Virus Vaccines
    1.3 Approved COVID-19 Vaccines Segment by Application
        1.3.1 Global Approved COVID-19 Vaccines Sales Comparison by Application: (2022-2028)
        1.3.2 Adults
        1.3.3 Children
        1.3.4 Elderly
    1.4 Global Approved COVID-19 Vaccines Market Size Estimates and Forecasts
        1.4.1 Global Approved COVID-19 Vaccines Revenue 2017-2028
        1.4.2 Global Approved COVID-19 Vaccines Sales 2017-2028
        1.4.3 Approved COVID-19 Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Approved COVID-19 Vaccines Market Competition by Manufacturers
    2.1 Global Approved COVID-19 Vaccines Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Approved COVID-19 Vaccines Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Approved COVID-19 Vaccines Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Approved COVID-19 Vaccines Manufacturing Sites, Area Served, Product Type
    2.5 Approved COVID-19 Vaccines Market Competitive Situation and Trends
        2.5.1 Approved COVID-19 Vaccines Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Approved COVID-19 Vaccines Players Market Share by Revenue
        2.5.3 Global Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Approved COVID-19 Vaccines Retrospective Market Scenario by Region
    3.1 Global Approved COVID-19 Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Approved COVID-19 Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Approved COVID-19 Vaccines Market Facts & Figures by Country
        3.3.1 North America Approved COVID-19 Vaccines Sales by Country
        3.3.2 North America Approved COVID-19 Vaccines Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Approved COVID-19 Vaccines Market Facts & Figures by Country
        3.4.1 Europe Approved COVID-19 Vaccines Sales by Country
        3.4.2 Europe Approved COVID-19 Vaccines Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Approved COVID-19 Vaccines Market Facts & Figures by Region
        3.5.1 Asia Pacific Approved COVID-19 Vaccines Sales by Region
        3.5.2 Asia Pacific Approved COVID-19 Vaccines Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Approved COVID-19 Vaccines Market Facts & Figures by Country
        3.6.1 Latin America Approved COVID-19 Vaccines Sales by Country
        3.6.2 Latin America Approved COVID-19 Vaccines Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa Approved COVID-19 Vaccines Market Facts & Figures by Country
        3.7.1 Middle East and Africa Approved COVID-19 Vaccines Sales by Country
        3.7.2 Middle East and Africa Approved COVID-19 Vaccines Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Approved COVID-19 Vaccines Historic Market Analysis by Type
    4.1 Global Approved COVID-19 Vaccines Sales Market Share by Type (2017-2022)
    4.2 Global Approved COVID-19 Vaccines Revenue Market Share by Type (2017-2022)
    4.3 Global Approved COVID-19 Vaccines Price by Type (2017-2022)
5 Global Approved COVID-19 Vaccines Historic Market Analysis by Application
    5.1 Global Approved COVID-19 Vaccines Sales Market Share by Application (2017-2022)
    5.2 Global Approved COVID-19 Vaccines Revenue Market Share by Application (2017-2022)
    5.3 Global Approved COVID-19 Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Moderna
        6.1.1 Moderna Corporation Information
        6.1.2 Moderna Description and Business Overview
        6.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Moderna Approved COVID-19 Vaccines Product Portfolio
        6.1.5 Moderna Recent Developments/Updates
    6.2 CanSino Biologicals
        6.2.1 CanSino Biologicals Corporation Information
        6.2.2 CanSino Biologicals Description and Business Overview
        6.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 CanSino Biologicals Approved COVID-19 Vaccines Product Portfolio
        6.2.5 CanSino Biologicals Recent Developments/Updates
    6.3 Inovio Pharmaceuticals
        6.3.1 Inovio Pharmaceuticals Corporation Information
        6.3.2 Inovio Pharmaceuticals Description and Business Overview
        6.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Portfolio
        6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
    6.4 Shenzhen Geno-Immune Medical Institute
        6.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
        6.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
        6.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Portfolio
        6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
    6.5 GlaxoSmithKine
        6.5.1 GlaxoSmithKine Corporation Information
        6.5.2 GlaxoSmithKine Description and Business Overview
        6.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Product Portfolio
        6.5.5 GlaxoSmithKine Recent Developments/Updates
    6.6 Pfizer
        6.6.1 Pfizer Corporation Information
        6.6.2 Pfizer Description and Business Overview
        6.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Pfizer Approved COVID-19 Vaccines Product Portfolio
        6.6.5 Pfizer Recent Developments/Updates
    6.7 Johnson＆Johnson
        6.6.1 Johnson＆Johnson Corporation Information
        6.6.2 Johnson＆Johnson Description and Business Overview
        6.6.3 Johnson＆Johnson Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Johnson＆Johnson Approved COVID-19 Vaccines Product Portfolio
        6.7.5 Johnson＆Johnson Recent Developments/Updates
    6.8 Heat Biologics
        6.8.1 Heat Biologics Corporation Information
        6.8.2 Heat Biologics Description and Business Overview
        6.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Heat Biologics Approved COVID-19 Vaccines Product Portfolio
        6.8.5 Heat Biologics Recent Developments/Updates
    6.9 Sanofi
        6.9.1 Sanofi Corporation Information
        6.9.2 Sanofi Description and Business Overview
        6.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Sanofi Approved COVID-19 Vaccines Product Portfolio
        6.9.5 Sanofi Recent Developments/Updates
7 Approved COVID-19 Vaccines Manufacturing Cost Analysis
    7.1 Approved COVID-19 Vaccines Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Approved COVID-19 Vaccines
    7.4 Approved COVID-19 Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Approved COVID-19 Vaccines Distributors List
    8.3 Approved COVID-19 Vaccines Customers
9 Approved COVID-19 Vaccines Market Dynamics
    9.1 Approved COVID-19 Vaccines Industry Trends
    9.2 Approved COVID-19 Vaccines Market Drivers
    9.3 Approved COVID-19 Vaccines Market Challenges
    9.4 Approved COVID-19 Vaccines Market Restraints
10 Global Market Forecast
    10.1 Approved COVID-19 Vaccines Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Approved COVID-19 Vaccines by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Approved COVID-19 Vaccines by Type (2023-2028)
    10.2 Approved COVID-19 Vaccines Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Approved COVID-19 Vaccines by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Approved COVID-19 Vaccines by Application (2023-2028)
    10.3 Approved COVID-19 Vaccines Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Approved COVID-19 Vaccines by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Approved COVID-19 Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Approved COVID-19 Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Approved COVID-19 Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Approved COVID-19 Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Approved COVID-19 Vaccines Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Approved COVID-19 Vaccines Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Approved COVID-19 Vaccines Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Approved COVID-19 Vaccines Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Approved COVID-19 Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Approved COVID-19 Vaccines Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Approved COVID-19 Vaccines Manufacturing Sites and Area Served
    Table 11. Manufacturers Approved COVID-19 Vaccines Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Approved COVID-19 Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Approved COVID-19 Vaccines as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Approved COVID-19 Vaccines Sales by Region (2017-2022) & (K Units)
    Table 16. Global Approved COVID-19 Vaccines Sales Market Share by Region (2017-2022)
    Table 17. Global Approved COVID-19 Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Approved COVID-19 Vaccines Revenue Market Share by Region (2017-2022)
    Table 19. North America Approved COVID-19 Vaccines Sales by Country (2017-2022) & (K Units)
    Table 20. North America Approved COVID-19 Vaccines Sales Market Share by Country (2017-2022)
    Table 21. North America Approved COVID-19 Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Approved COVID-19 Vaccines Revenue Market Share by Country (2017-2022)
    Table 23. Europe Approved COVID-19 Vaccines Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Approved COVID-19 Vaccines Sales Market Share by Country (2017-2022)
    Table 25. Europe Approved COVID-19 Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Approved COVID-19 Vaccines Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Approved COVID-19 Vaccines Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Approved COVID-19 Vaccines Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Approved COVID-19 Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Approved COVID-19 Vaccines Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Approved COVID-19 Vaccines Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Approved COVID-19 Vaccines Sales Market Share by Country (2017-2022)
    Table 33. Latin America Approved COVID-19 Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Approved COVID-19 Vaccines Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Approved COVID-19 Vaccines Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Approved COVID-19 Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Approved COVID-19 Vaccines Revenue Market Share by Country (2017-2022)
    Table 39. Global Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)
    Table 40. Global Approved COVID-19 Vaccines Sales Market Share by Type (2017-2022)
    Table 41. Global Approved COVID-19 Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Approved COVID-19 Vaccines Revenue Share by Type (2017-2022)
    Table 43. Global Approved COVID-19 Vaccines Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Approved COVID-19 Vaccines Sales (K Units) by Application (2017-2022)
    Table 45. Global Approved COVID-19 Vaccines Sales Market Share by Application (2017-2022)
    Table 46. Global Approved COVID-19 Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Approved COVID-19 Vaccines Revenue Share by Application (2017-2022)
    Table 48. Global Approved COVID-19 Vaccines Price by Application (2017-2022) & (US$/Unit)
    Table 49. Moderna Corporation Information
    Table 50. Moderna Description and Business Overview
    Table 51. Moderna Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Moderna Approved COVID-19 Vaccines Product
    Table 53. Moderna Recent Developments/Updates
    Table 54. CanSino Biologicals Corporation Information
    Table 55. CanSino Biologicals Description and Business Overview
    Table 56. CanSino Biologicals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. CanSino Biologicals Approved COVID-19 Vaccines Product
    Table 58. CanSino Biologicals Recent Developments/Updates
    Table 59. Inovio Pharmaceuticals Corporation Information
    Table 60. Inovio Pharmaceuticals Description and Business Overview
    Table 61. Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Inovio Pharmaceuticals Approved COVID-19 Vaccines Product
    Table 63. Inovio Pharmaceuticals Recent Developments/Updates
    Table 64. Shenzhen Geno-Immune Medical Institute Corporation Information
    Table 65. Shenzhen Geno-Immune Medical Institute Description and Business Overview
    Table 66. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product
    Table 68. Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
    Table 69. GlaxoSmithKine Corporation Information
    Table 70. GlaxoSmithKine Description and Business Overview
    Table 71. GlaxoSmithKine Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. GlaxoSmithKine Approved COVID-19 Vaccines Product
    Table 73. GlaxoSmithKine Recent Developments/Updates
    Table 74. Pfizer Corporation Information
    Table 75. Pfizer Description and Business Overview
    Table 76. Pfizer Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Pfizer Approved COVID-19 Vaccines Product
    Table 78. Pfizer Recent Developments/Updates
    Table 79. Johnson＆Johnson Corporation Information
    Table 80. Johnson＆Johnson Description and Business Overview
    Table 81. Johnson＆Johnson Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Johnson＆Johnson Approved COVID-19 Vaccines Product
    Table 83. Johnson＆Johnson Recent Developments/Updates
    Table 84. Heat Biologics Corporation Information
    Table 85. Heat Biologics Description and Business Overview
    Table 86. Heat Biologics Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Heat Biologics Approved COVID-19 Vaccines Product
    Table 88. Heat Biologics Recent Developments/Updates
    Table 89. Sanofi Corporation Information
    Table 90. Sanofi Description and Business Overview
    Table 91. Sanofi Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Sanofi Approved COVID-19 Vaccines Product
    Table 93. Sanofi Recent Developments/Updates
    Table 94. Production Base and Market Concentration Rate of Raw Material
    Table 95. Key Suppliers of Raw Materials
    Table 96. Approved COVID-19 Vaccines Distributors List
    Table 97. Approved COVID-19 Vaccines Customers List
    Table 98. Approved COVID-19 Vaccines Market Trends
    Table 99. Approved COVID-19 Vaccines Market Drivers
    Table 100. Approved COVID-19 Vaccines Market Challenges
    Table 101. Approved COVID-19 Vaccines Market Restraints
    Table 102. Global Approved COVID-19 Vaccines Sales Forecast by Type (2023-2028) & (K Units)
    Table 103. Global Approved COVID-19 Vaccines Sales Market Share Forecast by Type (2023-2028)
    Table 104. Global Approved COVID-19 Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 105. Global Approved COVID-19 Vaccines Revenue Market Share Forecast by Type (2023-2028)
    Table 106. Global Approved COVID-19 Vaccines Sales Forecast by Application (2023-2028) & (K Units)
    Table 107. Global Approved COVID-19 Vaccines Sales Market Share Forecast by Application (2023-2028)
    Table 108. Global Approved COVID-19 Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 109. Global Approved COVID-19 Vaccines Revenue Market Share Forecast by Application (2023-2028)
    Table 110. Global Approved COVID-19 Vaccines Sales Forecast by Region (2023-2028) & (K Units)
    Table 111. Global Approved COVID-19 Vaccines Sales Market Share Forecast by Region (2023-2028)
    Table 112. Global Approved COVID-19 Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 113. Global Approved COVID-19 Vaccines Revenue Market Share Forecast by Region (2023-2028)
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Approved COVID-19 Vaccines
    Figure 2. Global Approved COVID-19 Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Component Viral Vaccines Product Picture
    Figure 4. Whole Virus Vaccines Product Picture
    Figure 5. Global Approved COVID-19 Vaccines Market Share by Application in 2021 & 2028
    Figure 6. Adults
    Figure 7. Children
    Figure 8. Elderly
    Figure 9. Global Approved COVID-19 Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Approved COVID-19 Vaccines Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Approved COVID-19 Vaccines Sales (2017-2028) & (K Units)
    Figure 12. Approved COVID-19 Vaccines Sales Share by Manufacturers in 2021
    Figure 13. Global Approved COVID-19 Vaccines Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Approved COVID-19 Vaccines Players: Market Share by Revenue in 2021
    Figure 15. Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Approved COVID-19 Vaccines Sales Market Share by Region (2017-2022)
    Figure 17. Global Approved COVID-19 Vaccines Sales Market Share by Region in 2021
    Figure 18. Global Approved COVID-19 Vaccines Revenue Market Share by Region (2017-2022)
    Figure 19. Global Approved COVID-19 Vaccines Revenue Market Share by Region in 2021
    Figure 20. United States Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Colombia Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. UAE Approved COVID-19 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of Approved COVID-19 Vaccines by Type (2017-2022)
    Figure 44. Manufacturing Cost Structure of Approved COVID-19 Vaccines
    Figure 45. Manufacturing Process Analysis of Approved COVID-19 Vaccines
    Figure 46. Approved COVID-19 Vaccines Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Frequently Asked Questions
Approved COVID-19 Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Approved COVID-19 Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Approved COVID-19 Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports